The features of the production of interleukins-4, -8, -10 and -18 in normal third trimester pregnancy

Neklyudova, Anastasia V.; Белан, Э. Б.; Andreeva, Margarita V.; Kopan, S.V.

doi:10.19163/1994-9480-2023-20-2-74-77

Journal of Volgograd State Medical University

2023

DOI: 10.19163/1994-9480-2023-20-2-74-77

|View full text |Cite

The features of the production of interleukins-4, -8, -10 and -18 in normal third trimester pregnancy

Anastasia V. Neklyudova

Э. Б. Белан

Margarita V. Andreeva

et al.

Abstract: The serum level of ILL-4, -8, -10, -18 has been studied in 32 healthy women with uncomplicated pregnancy in comparison with nonpregnant women. It has been shown that the decreased production of ILL-4, -8, -10 and IL-8/IL-18 ratio, but increased production of IL-18 and IL-18/IL-10 ratio.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 12 publications

(2 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Pathogenetic Role of Changes Serum Level Interleukin-4 During Therapy for Ulcerative Colitis

Matveeva,

Mosina,

Kilovataya

et al. 2024

Mol Med Rus

View full text Add to dashboard Cite

Introduction. An important pathogenetic link in systemic inflammation in ulcerative colitis (UC) is dysregulation of the immune response. The aim of the study: to study pathogenetic changes in the serum level of interleukin (IL)-4 during UC therapy. Methods. 66 patients with ulcerative colitis were examined, of which 21 patients received genetically engineered biological drugs (GEBD), and 20 healthy volunteers. The amount of IL-4 was determined by enzyme immunoassay. Results. The content of IL-4 in the serum of patients significantly exceeded the values of the control group. Minimum cytokine values (3–4 pg/ml) were determined in 5 patients with severe UC activity and total intestinal lesions without GEBD therapy. Negative correlations between IL-4 values and the location of colitis and the severity of exacerbation were revealed. Achieving remission was accompanied by an increase in serum IL-4, which was less during GEBD therapy. Conclusion. A study of the IL-4 content in the blood serum of patients in the dynamics of UC revealed significant quantitative changes at different stages of the disease, exceeding the values of healthy volunteers. Restriction of overproduction of IL-4 as an anti-inflammatory cytokine can serve as a criterion for the effectiveness of therapy.

show abstract

Pathogenetic Role of Changes Serum Level Interleukin-4 During Therapy for Ulcerative Colitis

Matveeva,

Mosina,

Kilovataya

et al. 2024

Mol Med Rus

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

The features of the production of interleukins-4, -8, -10 and -18 in normal third trimester pregnancy

Abstract: The serum level of ILL-4, -8, -10, -18 has been studied in 32 healthy women with uncomplicated pregnancy in comparison with nonpregnant women. It has been shown that the decreased production of ILL-4, -8, -10 and IL-8/IL-18 ratio, but increased production of IL-18 and IL-18/IL-10 ratio.

Cited by 1 publication

References 12 publications

Pathogenetic Role of Changes Serum Level Interleukin-4 During Therapy for Ulcerative Colitis

Pathogenetic Role of Changes Serum Level Interleukin-4 During Therapy for Ulcerative Colitis

Contact Info

Product

Resources

About